Complications of fluoroscopically guided extraforaminal cervical nerve blocks: An analysis of 1036 injections by Ma, Daniel J., III et al.




Complications of fluoroscopically guided
extraforaminal cervical nerve blocks: An analysis of
1036 injections
Daniel J. Ma III
Washington University School of Medicine in St. Louis
Louis A. Gilula
Washington University School of Medicine in St. Louis
K. Daniel Riew
Washington University School of Medicine in St. Louis
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
Part of the Medicine and Health Sciences Commons
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Ma, Daniel J. III; Gilula, Louis A.; and Riew, K. Daniel, ,"Complications of fluoroscopically guided extraforaminal cervical nerve
blocks: An analysis of 1036 injections." The Journal of Bone and Joint Surgery.87,5. 1025-1030. (2005).
http://digitalcommons.wustl.edu/open_access_pubs/839
COPYRIGHT © 2005 BY THE JOURNAL OF BONE AND JOINT SURGERY, INCORPORATED
1025
Complications of Fluoroscopically 
Guided Extraforaminal 
Cervical Nerve Blocks
AN ANALYSIS OF 1036 INJECTIONS
BY DANIEL J. MA, MS III, LOUIS A. GILULA, MD, AND K. DANIEL RIEW, MD
Investigation performed at the Department of Radiology and the Cervical Spine Service, 
Department of Orthopaedic Surgery, Barnes-Jewish Hospital at Washington University School of Medicine, St. Louis, Missouri
Background: A number of serious complications associated with fluoroscopically guided extraforaminal cervical
nerve blocks have been reported in the literature. The purpose of the present study was to determine the rate of com-
plications associated with these blocks and to determine whether needle positioning during the procedure affected
the prevalence of complications at one institution.
Methods: Between October 1999 and June 2003, we performed 1036 fluoroscopically guided extraforaminal cervi-
cal nerve blocks in 844 patients. Plain radiographs documenting the procedure were made as part of the standard
quality-assurance protocol. An independent observer who was uninvolved with the procedures reviewed a prospec-
tively kept database on all patients. We subsequently reviewed the patient records to identify complications.
Results: There were no catastrophic complications such as vessel damage, paralysis, or death. Overall, fourteen pa-
tients (1.66%) had a minor complication in association with the procedure. With the numbers available, the rate of
complications associated with pdeep injection (798 blocks) was not significantly different from that associated with
shallow injection (238 blocks) (1.89% compared with 0.84%). However, the rate of complications associated with an-
terior placement of the needle tip (thirty-three blocks) was higher than that associated with ideal placement of the
needle tip (904 blocks) (6.06% compared with 1.55%) (p = 0.04).
Conclusions: No catastrophic complications occurred in this series of 1036 nerve blocks. We found that the medial-
lateral needle depth as seen on frontal-view radiographs was not associated with complications, although the ante-
rior positioning of the needle as seen on lateral-view radiographs was associated with minor complications. Our
results suggest that, with our technique, cervical nerve blocks are relatively safe procedures.
Level of Evidence: Therapeutic Level III. See Instructions to Authors for a complete description of levels of evidence.
luoroscopically guided extraforaminal cervical nerve
blocks are a noninvasive alternative to surgical treat-
ment1. In addition, they have been reported to be of
value in helping to determine the pain-generating level
preoperatively2. Fluoroscopic guidance was added as a means
of avoiding needle misplacement associated with blind cervi-
cal nerve blocks3.7
As with any nerve block, minor complications such as
headache, temporary pain, nausea, numbness, and weakness
have been associated with the procedure2. Alarmingly, there
have also been recent case reports of fatal spinal cord infarc-
tion4, injection into an anterior radicular artery5, and punc-
ture of the epidural sac of the nerve root sleeve1. In addition,
there has been concern regarding potential injury to the verte-
bral artery6. The potential for these and other catastrophic
complications, and the associated potential for litigation, have
anecdotally prompted some groups to advocate protocols that
maintain a shallow needle position and have influenced others
to cease performing the procedure altogether. Although infor-
mative, these alarming case reports may not accurately reflect
the true risks associated with the procedure. In order to ascer-
tain a more objective measure of associated risks, we reviewed
our experience with cervical nerve blocks to determine the
prevalence of catastrophic complications, including death, pa-
ralysis, spinal cord injury, stroke, vertebral artery injury, and
infection. In our review of the English-language literature, we
were unable to identify any large series that have examined the
complication rate associated with the procedure. We also in-
vestigated whether the depth and position of needle place-
ment as measured on frontal and lateral radiographs were
associated with the prevalence of minor complications, in-
cluding headache, numbness, pain, weakness, and nausea.
F
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Materials and Methods
ll patients who received a fluoroscopically guided extrafo-
raminal cervical nerve block at our institution between
October 1999 and June 2003 were included in the present ret-
rospective study. One thousand and thirty-six injections were
performed on 844 patients, for an average of 1.23 injections
per patient. The average age of the patients at the time of in-
jection was forty-seven years. Fifty-four percent of the pa-
tients were women, and 46% were men. The large majority of
patients had symptoms related to either disc herniation or fo-
raminal stenosis and had been referred by a single orthopaedic
spine surgeon (K.D.R.). Blocks were performed either for veri-
fication of a pathological nerve root level or to prevent or de-
lay the need for surgery. The injections were performed by or
under the direction of three attending radiologists in our radi-
ology department. All three radiologists used a standardized
technique, which was verified prospectively by the senior radi-
ologist (L.A.G.) by means of a quality-assurance review of all
of the injections.
Before the procedure, each patient completed a form in-
dicating the distribution pattern of pain as well as the severity
of pain on a scale from 0 to 10. For the procedure, the patient
was placed in the lateral decubitus position with the side of in-
terest elevated. C-arm fluoroscopy was used to place a 25-
gauge needle into the extraforaminal area of the level of inter-
est. The needle was inserted to slide along the anterior surface
of the articular pillar (lateral mass) and was kept as posterior as
possible in order to avoid the vertebral artery. To ascertain that
the needle tip was not located in a vascular structure, myelo-
graphic contrast material (iohexol) (Omnipaque 180 or 300;
Amersham Health, Princeton, New Jersey) was injected prior
to the injection of the anesthetic and medication mixture.
Once the needle was adequately positioned, 1 mL of Celestone
Soluspan (betamethasone sodium phosphate and betametha-
sone acetate; Schering-Plough, Chatsworth, Georgia) with 0.5
mL of preservative-free 2% lidocaine or Xylocaine, or 0.5 mL
of methylprednisolone acetate suspension (DepoMedrol 80
mg/mL; Pharmacia-Upjohn, Kalamazoo, Michigan) with 0.5
mL of 2% preservative-free Xylocaine and 0.5 mL Omnipaque
180 or 300, for a total volume of 1.5 mL, was injected. De-
poMedrol was used later in the study period as Celestone be-
came unavailable commercially. Images were made during and
after injection to verify needle tip placement.
A duplicate fluoroscopic record of each procedure was
obtained prospectively as part of our standard quality-assurance
protocol. Every patient was observed for ten to twenty minutes
after the injection and was given a follow-up form regarding
pain. Immediate pain relief and complications were recorded in
the dictated radiographic report. Patients were instructed to
contact the referring doctor if delayed complications oc-
curred. An independent observer (D.J.M.) who had not been
involved in the procedures reviewed a prospectively kept data-
base on all patients who had undergone cervical nerve blocks
during the study period. Radiographs were reviewed, and the
needle position in both the frontal and lateral views was noted
and labeled. Uncertainties about needle position were resolved
by means of a consensus between the independent reviewer
and the radiologist (L.A.G.).
On the frontal view, needle depth was measured with
use of the lateral mass as a marker. Needle tips that were pe-
ripheral to the lateral border of the lateral mass were labeled as
being in Zone 1. Needle tips overlying the lateral mass but lat-
eral to the midline were labeled as being in Zone 2. Needle tips
overlying the medial half of the lateral mass but within the
A
Fig. 1
Frontal view of a cervical spine model, demonstrating the boundaries of the various frontal 
zones. (See the text for a description of Zones 1 through 4.)
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mass were labeled as being in Zone 3. Needle tips medial to
the lateral mass were labeled as being in Zone 4 (Fig. 1). Nee-
dle tips that were on the boundary between zones were labeled
as being within the deeper zone.
On the lateral view, ideal needle placement (defined as
placement directly on the anterior edge of the lateral mass)
was labeled as Zone A. Needle positions that were within two
needle-tip diameters anterior to Zone A were labeled as Zone
B. Positions further anterior than Zone B were labeled as Zone
C (Fig. 2). Radiographs with inadequate lateral views were la-
beled U. Radiographs were labeled inadequate if the lateral
masses did not overlap by at least 50%.
A thorough review of a list of complications concurrently
recorded by the radiology department as well as of all procedure
reports was performed to identify which procedures were asso-
ciated with complications. These complications were matched
to the needle position within the radiographic image. Institu-
tional review board approval was obtained for this retrospec-
tive study.
Results
o catastrophic complications such as death, paralysis,
stroke, spinal cord injury, vertebral artery injury, or in-
fection were recorded. Seventeen injections (1.64%) were as-
sociated with complications, most of which were minor and
transient (Tables I and II). Two patients with complications
had had multiple injections: one had had two simultaneous
injections, and the other had had three. Thus, a total of four-
teen patients (1.66%) had a complication in association with
the procedure. Ninety-nine injections were excluded because
of an inadequate lateral fluoroscopic record. None of these in-
jections were associated with any reported complications, and
all were excluded only because of the inability to analyze the
radiographs.
The prevalence of minor complications according to
needle position is summarized in Table I. The complications
that were encountered are summarized in Table II. Three pa-
tients had symptoms that probably were linked to uncon-
trolled diabetes, concomitant neurological findings, or alcohol
consumption, but we included them for completeness. One
patient who had transient global amnesia, dizziness, and nau-
sea was admitted to the hospital overnight and had a thorough
neurological workup, which revealed negative findings. The
dizziness had resolved by two weeks.
In addition to the fourteen patients who had complica-
tions, two patients received the injection at the wrong level
N
Fig. 2
Lateral radiograph of the cervical spine, demonstrating 
the boundaries of various lateral zones. (See the text for 
a description of Zones A, B, and C).









Zone 1 1 0%
Zone 2 237 0.84%
Zone 3 792 2.15%
Zone 4 6 1.89%
Lateral Zones
Zone A 794 1.51%
Zone B 110 1.81%
Zone C 33 6.06%
Zone U 99 1.01%
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and one patient received a facet block instead of a nerve block.
While the wrong-level injections and the facet injection did
not produce complications, they do nevertheless represent
complications of the procedure. For the purposes of statistical
analysis, however, we did not consider these procedural errors
as complications.
Chi-square tests were performed to determine whether
there were any significant differences in the rate of complica-
tions associated with differences in needle placement. Analysis
of needle tip depth on the frontal view revealed no significant
difference, with the numbers available, between the rate of
complications associated with deep injections (Zones 3 and 4;
798 blocks) and that associated with superficial injections
(Zones 1 and 2; 238 blocks) (p = 0.31). Analysis of needle
placement on the lateral view, however, demonstrated a signifi-
cant result. Specifically, the rate of complications associated
with skewed (anterior) placement of the needle tip (Zone C;
thirty-three blocks) was significantly higher than that associ-
ated with ideal or near-ideal placement of the needle tip (Zones
A and B; 904 blocks) (p = 0.04). 
Discussion
everal small series have established the efficacy of fluoro-
scopically guided extraforaminal cervical nerve blocks7-9.
The complications associated with this procedure, however,
have only been mentioned in passing in those articles as well
as in isolated case reports8. To our knowledge, the present
study represents the largest reported series of such blocks to
date as well as the only study that has focused on the compli-
cations of such blocks.
Several articles have described catastrophic complica-
tions that have occurred in association with fluoroscopically
guided extraforaminal cervical nerve blocks3-6. Intravascular
penetration has always been the primary concern related to
this procedure. Furman et al. attempted to address this con-
cern by detailing the prevalence of intravascular penetration
associated with transforaminal procedures10. However, none
of their 337 patients experienced symptoms associated with
intravascular contrast medium because the needle was imme-
diately repositioned if any contrast medium was found to pass
intravascularly. Our study confirmed this finding. The risks of
intravascular injection can be minimized by injecting con-
trast medium before performing the nerve block. We observed
none of the catastrophic complications that have been associ-
ated with intravascular penetration, and we have modified our
injection procedure to avoid intravascular injection by adding
S







Transient neurologic deficits (pain or weakness) 6
Hypersensitivity reaction 1
Vasovagal reaction 1
Transient global amnesia 1
Total 14
Wrong-site injection 




Fig. 3-A Oblique radiograph demonstrating the needle tip and contrast medium projecting over the posterior aspect of the extraforaminal area. 
Fig. 3-B Lateral radiograph of the same patient. What appeared to be an adequate needle tip position on the oblique radiograph is actually an ante-
riorly placed needle tip position on the true lateral radiograph.
Fig. 3-B
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contrast medium to the final injectate. Another method for
preventing intravascular injection is to attach the needle to a
thin-walled, short lymphangiographic tube (MX453; Medex,
Dalton, Ohio) through which contrast medium can be in-
jected. Another syringe containing the injectate can then be
attached to the free end of the connecting tube to inject the
medication, thereby eliminating the need to retouch the nee-
dle to instill the injectate11.
The International Spine Injection Society and Windsor
et al. recommend frontal and oblique radiographic views for
verification of needle tip position12,13. The importance of lat-
eral views was not stressed. It has been our experience, how-
ever, that an apparently adequate needle position as seen on
the oblique view does not necessarily translate into an ade-
quate needle position on the lateral view (Figs. 3-A and 3-B).
In order to prevent damage to the vertebral artery, we rou-
tinely keep the needle close to the anterior surface of the lat-
eral mass, a position that can only be ascertained on a true
lateral view. This is relevant because we also found that anteri-
orly positioned needles were associated with a higher compli-
cation rate than more posteriorly positioned needles were.
As with any study, the present study is not without
flaws. This was a retrospective study and therefore is con-
strained by the limitations of such analyses. As is the case with
all retrospective studies, we cannot be certain if there were any
unreported complications that occurred. Our standard policy
was to inform the patient of the potential known or probable
complications of the procedure, including all of the complica-
tions that we have analyzed. All patients were observed in the
radiology department postoperatively in order to identify any
immediate complications, which were duly recorded. Upon
discharge, the patients were given specific instructions about
how to contact the radiology department in order to notify us
of any late complications. In addition, all patients were in-
structed to contact the referring doctor, both to notify him or
her of the results of the injection as well as to report any com-
plications. Despite all of these precautions, we believe that it is
quite probable that a certain number of patients may have suf-
fered a minor complication without informing the physicians
or that the referring doctor may have neglected to inform the
radiologist. However, problems such as death, stroke, and pa-
ralysis are not subtle findings and cannot be ignored or self-
treated by the patient. We believe that it is highly unlikely that
these catastrophic events could have occurred without our
knowledge. As stated previously, all patients were requested to
fill out a post-injection questionnaire regarding the immedi-
ate and one-week results. While we did not specifically use the
questionnaire to detect complications, we believe it provided
the patients with an additional means of informing their refer-
ring doctors of any complications.
Another shortcoming of our study is that the static fluo-
roscopic image that we utilized to analyze the position of the
needle recorded only where the needle was at the time that the
image was made. However, we took specific precautions to
prevent accidental movement of the needle during the proce-
dure. All of the injections were performed under fluoroscopic
control, and the needle was repositioned correctly if any
movement was detected on the fluoroscopic image. Also, a
post-injection image was made to verify the position of the
needle tip. Therefore, we believe that the spot image that was
recorded reasonably reflects the actual location of the injec-
tion. As with any technique-dependent procedure, our results
will not be universally reproducible. Nevertheless, we believe
that, in competent hands, our results will be reproducible at
other institutions as there were no apparent differences with
regard to complication rates among the three radiologists at
our institution.
In conclusion, case reports on complications can be un-
necessarily alarming in that they most often do not provide
the prevalence of such complications. We undertook the
present study on nerve blocks that had been performed at a
single institution to put such complications into perspective.
There were no catastrophic complications, and the rate of mi-
nor complications was low. We believe that the risk of compli-
cations can be further minimized by positioning the needle as
posteriorly as possible, hugging the anterior wall of the lateral
mass. Our results suggest that, in experienced hands, the de-
scribed technique for cervical nerve root blocks has an accept-
able safety profile. 
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